• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

北极星动态评估在杜氏肌营养不良症男童中的适用性。

Suitability of North Star Ambulatory Assessment in young boys with Duchenne muscular dystrophy.

作者信息

De Sanctis Roberto, Pane Marika, Sivo Serena, Ricotti Valeria, Baranello Giovanni, Frosini Silvia, Mazzone Elena, Bianco Flaviana, Fanelli Lavinia, Main Marion, Corlatti Alice, D'Amico Adele, Colia Giulia, Scalise Roberta, Palermo Concetta, Alfonsi Chiara, Tritto Giovanna, Romeo Domenico M, Graziano Alessandra, Battini Roberta, Morandi Lucia, Bertini Enrico, Muntoni Francesco, Mercuri Eugenio

机构信息

Department of Paediatric Neurology, Catholic University, Rome, Italy.

Dubowitz Neuromuscular Centre, Institute of Child Health, University College, London, United Kingdom.

出版信息

Neuromuscul Disord. 2015 Jan;25(1):14-8. doi: 10.1016/j.nmd.2014.09.015. Epub 2014 Oct 6.

DOI:10.1016/j.nmd.2014.09.015
PMID:25454732
Abstract

The aim of this study was to establish the suitability of the North Star Ambulatory Assessment for use in young boys with Duchenne muscular dystrophy. We studied 147 typically developing and 144 boys affected by Duchenne muscular dystrophy between the ages of 3 and 5 years. More than 85% of the typically developing boys by the age of 4 years had full scores on all the items with total scores ≥33/34. Before the age of 4 years more than 15% of the typically developing boys did not achieve full scores on all the items. Some items, such as standing on one leg, showed significant improvement with age. In contrast, other activities were rarely achieved even in the older boys. Even if there was a progressive increase in scores with age, both total and individual item scores in Duchenne were still far from those obtained in the typically developing children of the same age. Our findings suggest that the North Star Ambulatory Assessment can be reliably used at least from the age of 4 years. Longitudinal natural history data studies are needed to assess possible changes over time and the possible effect of early steroids.

摘要

本研究的目的是确定北极星动态评估在患有杜氏肌营养不良症的幼龄男孩中的适用性。我们研究了147名发育正常的男孩以及144名年龄在3至5岁之间患有杜氏肌营养不良症的男孩。超过85%发育正常的4岁男孩在所有项目上都获得了满分,总分≥33/34。4岁之前,超过15%发育正常的男孩在所有项目上未获得满分。一些项目,如单腿站立,随着年龄增长有显著改善。相比之下,其他活动即使在年龄较大的男孩中也很少能完成。尽管随着年龄增长分数有逐渐提高,但杜氏肌营养不良症患儿的总分和单项分数仍远低于同龄发育正常儿童。我们的研究结果表明,北极星动态评估至少从4岁起就可以可靠使用。需要进行纵向自然史数据研究,以评估随时间可能发生的变化以及早期使用类固醇的可能影响。

相似文献

1
Suitability of North Star Ambulatory Assessment in young boys with Duchenne muscular dystrophy.北极星动态评估在杜氏肌营养不良症男童中的适用性。
Neuromuscul Disord. 2015 Jan;25(1):14-8. doi: 10.1016/j.nmd.2014.09.015. Epub 2014 Oct 6.
2
Revised North Star Ambulatory Assessment for Young Boys with Duchenne Muscular Dystrophy.修订版北星动态评估用于杜氏肌营养不良症男孩
PLoS One. 2016 Aug 5;11(8):e0160195. doi: 10.1371/journal.pone.0160195. eCollection 2016.
3
North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy.北极星门诊评估、6 分钟步行试验和能走动的杜氏肌营养不良症男孩的计时项目。
Neuromuscul Disord. 2010 Nov;20(11):712-6. doi: 10.1016/j.nmd.2010.06.014. Epub 2010 Jul 14.
4
Longitudinal natural history in young boys with Duchenne muscular dystrophy.Duchenne 型肌营养不良症男童的纵向自然病史。
Neuromuscul Disord. 2019 Nov;29(11):857-862. doi: 10.1016/j.nmd.2019.09.010. Epub 2019 Sep 26.
5
Reliability and validity analyses of the North Star Ambulatory Assessment in Brazilian Portuguese.《北极星动态评估量表巴西葡萄牙语版的信效度分析》
Neuromuscul Disord. 2017 Aug;27(8):723-729. doi: 10.1016/j.nmd.2017.05.013. Epub 2017 May 26.
6
Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy.迈向有意义的测量:Rasch 分析在杜氏肌营养不良症中的北极星门诊评估。
Dev Med Child Neurol. 2011 Jun;53(6):535-42. doi: 10.1111/j.1469-8749.2011.03939.x. Epub 2011 Mar 17.
7
Ankle contractures and functional motor decline in Duchenne muscular dystrophy.杜氏肌营养不良症的踝关节挛缩和运动功能下降。
Brain Dev. 2022 Feb;44(2):105-113. doi: 10.1016/j.braindev.2021.09.007. Epub 2021 Oct 8.
8
Categorising trajectories and individual item changes of the North Star Ambulatory Assessment in patients with Duchenne muscular dystrophy.对杜氏肌营养不良症患者的北极星动态评估的轨迹和单项变化进行分类。
PLoS One. 2019 Sep 3;14(9):e0221097. doi: 10.1371/journal.pone.0221097. eCollection 2019.
9
Composite biomarkers for assessing Duchenne muscular dystrophy: an initial assessment.用于评估杜氏肌营养不良症的复合生物标志物:初步评估
Pediatr Neurol. 2015 Feb;52(2):202-5. doi: 10.1016/j.pediatrneurol.2014.09.014. Epub 2014 Oct 7.
10
Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes.进行性肌营养不良症行走期男孩的长期自然病史数据:36个月的变化
PLoS One. 2014 Oct 1;9(10):e108205. doi: 10.1371/journal.pone.0108205. eCollection 2014.

引用本文的文献

1
Gait Characterization in Duchenne Muscular Dystrophy (DMD) Using a Single-Sensor Accelerometer: Classical Machine Learning and Deep Learning Approaches.使用单传感器加速度计对杜氏肌营养不良症(DMD)进行步态特征分析:经典机器学习和深度学习方法。
Sensors (Basel). 2024 Feb 8;24(4):1123. doi: 10.3390/s24041123.
2
Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies - Developing Potential Treatments for the Entire Spectrum of Disease.行业指南草案:杜氏肌营养不良症、贝克肌营养不良症和相关肌营养不良症——为整个疾病谱开发潜在的治疗方法。
J Neuromuscul Dis. 2024;11(2):499-523. doi: 10.3233/JND-230219.
3
Quantifying Variability in Motor Function in Duchenne Muscular Dystrophy: UK Centiles for the NorthStar Ambulatory Assessment, 10 m Walk Run Velocity and Rise from Floor Velocity in GC Treated Boys.
量化杜氏肌营养不良症运动功能的变异性:经 GC 治疗的男孩的 NorthStar 助行器评估、10 米步行跑速度和从地板上升速度的英国百分位数。
J Neuromuscul Dis. 2024;11(1):153-166. doi: 10.3233/JND-230159.
4
Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers.正交蛋白质组学方法有助于杜氏肌营养不良症生物标志物的开发。
Clin Proteomics. 2023 Jun 12;20(1):23. doi: 10.1186/s12014-023-09412-1.
5
Disease progression modeling of the North Star Ambulatory Assessment for Duchenne Muscular Dystrophy.杜氏肌营养不良症北美之星门诊评估疾病进展建模。
CPT Pharmacometrics Syst Pharmacol. 2023 Mar;12(3):375-386. doi: 10.1002/psp4.12921. Epub 2023 Feb 14.
6
Age, corticosteroid treatment and site of mutations affect motor functional changes in young boys with Duchenne Muscular Dystrophy.年龄、皮质类固醇治疗和突变部位影响年轻杜氏肌营养不良症男孩的运动功能变化。
PLoS One. 2022 Jul 29;17(7):e0271681. doi: 10.1371/journal.pone.0271681. eCollection 2022.
7
Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.不同剂量皮质类固醇方案对杜氏肌营养不良症男童临床结局的影响:一项随机临床试验。
JAMA. 2022 Apr 19;327(15):1456-1468. doi: 10.1001/jama.2022.4315.
8
A video game based hand grip system for measuring muscle force in children.基于视频游戏的手握系统,用于测量儿童的肌肉力量。
J Neuroeng Rehabil. 2021 Jul 10;18(1):113. doi: 10.1186/s12984-021-00908-1.
9
Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy.血液生物标志物与杜氏肌营养不良症的临床进展相关。
J Neuromuscul Dis. 2020;7(3):231-246. doi: 10.3233/JND-190454.
10
Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial.他莫昔芬治疗杜氏肌营养不良症(TAMDMD):一项多中心、随机、安慰剂对照、双盲3期试验的研究方案
Trials. 2019 Nov 21;20(1):637. doi: 10.1186/s13063-019-3740-6.